Tag: Pf Magazine January 2019

In Depth

How to engage payers in the NHS

Tim Warren -
Paper Aeroplanes and Compass showing Challenging traditional CSO
Spotlight: Advertorial from Pf Partners

Challenging traditional CSO

Clive Scragg -
Man looking at sign showing cross roads for NHS commissioning
Healthcare

Is pharma prepared for future NHS commissioning?

Emma Hedges -
Vital child health information to be made digitally available
In Depth

The importance of patient engagement

Craig Bradley -
People standing demonstrating NHS leadership gender gap
In Depth

Closing the NHS leadership gender gap

Emma Clayton -
GSK has been placed fourth in LinkedIn's 2019 list of best places to work in the UK
In Depth

Tackling gender diversity in pharma leadership

Seb Burchell -
Helen Westropp on the soft factors in M&A
In Depth

The importance of soft factors in M&A

Helen Westropp -
Mark Ward, Operations Director at Star, on taking control of your career
Spotlight: Advertorial from Pf Partners

Mark Ward, Operations Director at Star, on taking control of your...

Mark Ward -
AI the future of medicine
In Depth

Is AI the future of medicine?

Andrew Pannifer -
Man at desk depicting the Royal Society of Chemistry’s Emerging Technologies Competition 2019
In Depth

The importance of data process in the pharma industry

Rob Hodgson -
12Page 1 of 2

Latest articles

healthcare professionals in PPE to show Major study into COVID-19 long-term health effects

Major study into COVID-19 long-term health effects

COVID-19 Emma Morriss -
The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...
Image of a scale held by a hand with one business person on the left and a group balancing on the right to show Crisis or crossroads? Where next for key account management post-COVID?

Crisis or crossroads? Key account management post-COVID

In Depth Miranda Wheatley Price -
Miranda Wheatley Price from Rubica calls for a dynamic response to the current challenge as she explores the future for key account management post-COVID. One...
Image of a mac and desk setup to show Pf Webinars: Shaping healthcare markets to serve real brand purpose

Pf Webinars: Shaping healthcare markets to serve real brand purpose

Marketing Emma Morriss -
Pf's third FREE webinar in conjunction with Triducive and E4H focuses on shaping healthcare markets to serve real brand purpose. As healthcare markets are evolve...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

COVID-19 Mark Pringle -
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scale held by a hand with one business person on the left and a group balancing on the right to show Crisis or crossroads? Where next for key account management post-COVID?

Crisis or crossroads? Key account management post-COVID

In Depth Miranda Wheatley Price -
Miranda Wheatley Price from Rubica calls for a dynamic response to the current challenge as she explores the future for key account management post-COVID. One...
healthcare professionals in PPE to show Major study into COVID-19 long-term health effects

Major study into COVID-19 long-term health effects

COVID-19 Emma Morriss -
The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

COVID-19 Amy Schofield -
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Image of a contract being signed by two people with a certification stamp to show European Commission approves extended Invokana ® (canagliflozin) indication

European Commission approves extended Invokana ® (canagliflozin) indication

Pharma News Emma Morriss -
The European Commission has approved an extended Invokana ® (canagliflozin) indication to reflect improved renal outcomes in patients with diabetic kidney disease and type...
Pharma and healthcare news, features and events | Pharmaceutical jobs and career advice | Pharma opinion, analysis and thought leadership

© Pharmafield all rights reserved . Pharmafield is part of the Events4Healthcare Group
Contact us: hello@pharmafield.co.uk
Terms & Conditions | Privacy Policy

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription